TrialMatchAI
About TrialMatchAI
TrialMatchAI is an AI-powered recommendation system designed to automate and streamline the process of matching patients to eligible clinical trials. It addresses the significant bottleneck of patient recruitment in clinical research, which often leads to delays in bringing new treatments to patients. The system processes heterogeneous clinical data, including structured records and unstructured physician notes, leveraging fine-tuned, open-source large language models (LLMs) within a retrieval-augmented generation (RAG) framework. This approach ensures transparency and reproducibility, and allows for a lightweight deployment suitable for clinical environments.
For physicians, TrialMatchAI offers a tool to quickly identify relevant clinical trials for their patients. It allows doctors to input a patient’s clinical case description in plain language, and the system returns a list of actively enrolling trials. The platform also integrates with existing physician communities, such as Mednet, where oncologists can describe a patient profile and receive matched trials based on factors like diagnosis, stage, biomarkers, and location. The results include match rationales and enrollment links, enabling physicians to efficiently evaluate potential opportunities within their clinical workflow. The system is designed for modularity and privacy, supporting standardized data formats like Phenopackets and enabling secure local deployment, ensuring patient data never leaves the local environment.
Focus Areas
Business Intelligence
| Key Investors | National Cancer Institute (NCI) (for Mednet's TrialMatch, a related tool) |
| Partnerships | SWOG Cancer Research Network (with Mednet for TrialMatch) |
| Acquisitions | unknown |
| Technology | Cloud-native, leverages fine-tuned open-source large language models (LLMs) within a Retrieval-Augmented Generation (RAG) framework, hybrid search strategy (lexical and vector search via Elasticsearch), medical Chain-of-Thought reasoning, supports Phenopackets-standardized data, local deployment capability |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
TrialMatchAI can significantly reduce the time spent on manual chart review for clinical trial eligibility, allowing physicians to focus more on patient care. The system provides explainable outputs with clear rationales for inclusion and exclusion, building confidence in the AI's recommendations. By identifying eligible patients earlier and surfacing trials that might otherwise be missed, TrialMatchAI broadens therapeutic options for patients, especially in complex areas like biomarker-driven oncology trials. Its ability to process unstructured physician notes means more comprehensive patient data is considered, leading to more accurate matches. The local deployment option ensures patient data privacy and security.
TrialMatchAI is designed for modularity and supports Phenopackets-standardized data, facilitating semantic interoperability. It can ingest structured trial metadata (e.g., from clinicaltrials.gov XML files) and patient records. While it supports Phenopackets, healthcare sites may need a local adapter (e.g., from FHIR) to produce Phenopackets with relevant patient information for full operational EHR interoperability. The system utilizes Elasticsearch for hybrid search strategies. The open-source nature and configurable model components allow for integration and fine-tuning within existing clinical environments.
What the Web Says
TrialMatchAI is an open-source, AI-powered system designed to automate and streamline the patient-to-clinical trial matching process, which traditionally relies on manual review. The system utilizes large language models (LLMs) and a Retrieval-Augmented Generation (RAG) framework to process diverse clinical data, including structured records and unstructured physician notes. It aims to improve the efficiency and accuracy of identifying eligible patients for clinical trials, particularly in precision medicine and oncology.
Overall: MixedStrengths
- High accuracy in identifying relevant trials and classifying eligibility criteria (over 90%).
- Automates a labor-intensive manual process, potentially saving time for healthcare professionals.
- Leverages advanced AI, including fine-tuned open-source LLMs within a RAG framework.
- Designed for transparency, reproducibility, and lightweight, local deployment, ensuring patient data privacy.
- Can process heterogeneous clinical data, including structured and unstructured notes.
- Provides criterion-level explanations for inclusion and exclusion decisions, enhancing interpretability.
Limitations
- While highly accurate in matching, it may not directly increase patient enrollment due to other barriers like logistics, financial toxicity, and patient understanding of experimental drugs.
- Requires a GPU for the initial heavy setup phase.
- The technology for patient-to-trial matching already exists in various forms from other providers.
- Deployment involves work to ensure data access.
- It is for research and informational use only and not intended to replace review by qualified healthcare professionals.
- No specific employer reviews were found for TrialMatchAI, and general reviews for similar AI matching services on Reddit indicate mixed experiences with some services not providing significant help.
Based on reviews from: Moonlight, Roupen Odabashian (LinkedIn), Semantic Scholar, MDLinx, PMC, GitHub, ResearchGate, Reddit
Last updated: 2026-08-25
Videos
News, demos, and interviews about TrialMatchAI.
Videos load interactively. If none appear, search YouTube for TrialMatchAI →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]